ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

383 hedge funds and large institutions have $8.08B invested in Intra-Cellular Therapies Inc. in 2024 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 132 increasing their positions, 136 reducing their positions, and 30 closing their positions.

Holders
383
Holders Change
+32
Holders Change %
+9.12%
% of All Funds
5.1%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
69
Increased
132
Reduced
136
Closed
30
Calls
$25.4M
Puts
$11M
Net Calls
+$14.4M
Net Calls Change
+$1.74M

Top Buyers

1
Norges Bank
1
Norges Bank
Norway
$268M
2
Raymond James Financial
2
Raymond James Financial
Florida
$76.5M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$56.6M
4
TCM
4
TimesSquare Capital Management
New York
$70.2M
5
DTC
5
Deep Track Capital
Connecticut
$167M

Top Sellers

1
WA
1
Wasatch Advisors
Utah
$271M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$37.7M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$49.3M
4
PA
4
Perceptive Advisors
New York
$108M
5
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$62M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$74.5M 892,386 +56,176 +7%
TCM
27
TimesSquare Capital Management
New York
$70.2M 840,269 +402,186 +92%
Deutsche Bank
28
Deutsche Bank
Germany
$64.8M 776,028 -90,727 -10%
First Trust Advisors
29
First Trust Advisors
Illinois
$64M 766,134 +85,883 +13%
Schroder Investment Management Group
30
Schroder Investment Management Group
United Kingdom
$62M 743,230 -180,941 -20%
Adage Capital Partners
31
Adage Capital Partners
Massachusetts
$56.6M 678,000 +493,000 +266%
HRCM
32
Hood River Capital Management
Florida
$51.4M 615,161 +15,170 +3%
Northern Trust
33
Northern Trust
Illinois
$50.9M 609,777 +117,846 +24%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$49.3M 589,906 -452,549 -43%
Principal Financial Group
35
Principal Financial Group
Iowa
$46M 550,963 -46,750 -8%
Macquarie Group
36
Macquarie Group
Australia
$45.5M 544,532 -162,169 -23%
AQR Capital Management
37
AQR Capital Management
Connecticut
$44.8M 536,781 +74,949 +16%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$44.6M 534,461 +165,781 +45%
Ameriprise
39
Ameriprise
Minnesota
$43.6M 522,563 -7,633 -1%
Millennium Management
40
Millennium Management
New York
$43.5M 520,826 +21,526 +4%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$43.4M 519,253 +31,331 +6%
BNP Paribas Asset Management
42
BNP Paribas Asset Management
France
$43.4M 519,083 +64,545 +14%
Lord, Abbett & Co
43
Lord, Abbett & Co
New Jersey
$43.2M 516,719 -112,120 -18%
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
$37.7M 451,146 -479,984 -52%
EA
45
Emerald Advisers
Pennsylvania
$36.6M 438,066 -3,230 -0.7%
Walleye Capital
46
Walleye Capital
New York
$32M 383,591 +134,203 +54%
NNPTE
47
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$31.8M 380,423 -24,233 -6%
Goldman Sachs
48
Goldman Sachs
New York
$31.4M 376,417 -79,613 -17%
DCM
49
Driehaus Capital Management
Illinois
$30.9M 369,617 +20,199 +6%
Bank of America
50
Bank of America
North Carolina
$30.4M 364,370 -58,139 -14%
1
2
3 4 5